 Connection
Kelly Knupp to Child, Preschool
This is a "connection" page, showing publications Kelly Knupp has written about Child, Preschool.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.872 |
|
|
|
-
Knupp KG, Scheffer IE, Schoonjans AS, Sullivan J, Lagae L, Auvin S, Thiele EA, Guerrini R, Zuberi SM, Nabbout R, Riney K, Nickels KC, Davis R, Lock MD, Dai D, Minh T, Zhang Roper R, Dickson N, Langlois M, Lothe A, Gil-Nagel A. Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers. Epilepsy Behav. 2025 Dec; 173:110753.
Score: 0.079
-
Mason JA, Juarez-Colunga E, Knupp KG. Electrographic screening for infantile epileptic spasms syndrome in a single sleep-wake cycle. Epilepsia. 2024 Jun; 65(6):1737-1743.
Score: 0.071
-
McGarry L, Messer R, Cree-Green M, Ray K, Knupp K. Incidence of Hypertension Among Children Treated With Adrenocorticotropic Hormone (ACTH) or Prednisolone for Infantile Spasms. J Child Neurol. 2020 03; 35(3):215-220.
Score: 0.053
-
Knupp KG, Rice JD, Helmkamp LJ, Galinkin J, Sempio C, Jost K, Chapman KE. Prospective evaluation of oral cannabis extracts in children with epilepsy. Seizure. 2019 Nov; 72:23-27.
Score: 0.052
-
Kelley SA, Knupp KG. Infantile Spasms-Have We Made Progress? Curr Neurol Neurosci Rep. 2018 04 19; 18(5):27.
Score: 0.047
-
Eschbach K, Scarbro S, Juarez-Colunga E, Allen V, Hsu S, Knupp K. Growth and endocrine function in children with Dravet syndrome. Seizure. 2017 Nov; 52:117-122.
Score: 0.045
-
Knupp KG, Scarbro S, Wilkening G, Juarez-Colunga E, Kempe A, Dempsey A. Parental Perception of Comorbidities in Children With Dravet Syndrome. Pediatr Neurol. 2017 Nov; 76:60-65.
Score: 0.044
-
Treat L, Chapman KE, Colborn KL, Knupp KG. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients. Epilepsia. 2017 01; 58(1):123-127.
Score: 0.043
-
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD, Mytinger JR, Joshi S, Shellhaas RA, Sullivan J, Dlugos D, Hamikawa L, Berg AT, Millichap J, Nordli DR, Wirrell E. Response to treatment in a prospective national infantile spasms cohort. Ann Neurol. 2016 Mar; 79(3):475-84.
Score: 0.040
-
Kuperman R, Blanco NJ, Buchhalter J, Kessler S, Knupp K, Lin N, Kremer K, Aungaroon G. Novel Smartphone-Based Screening Tool for Absence Seizures in Pediatric Settings: A Comparative Study With Video EEG. Pediatr Neurol. 2026 Jul; 180:52-58.
Score: 0.021
-
Laux L, Sullivan J, Perry MS, Brunklaus A, Desurkar A, Schreiber JM, Roberts CM, Knupp KG, Wheless JW, Wirrell EC, Ventola P, Wang F, Lynch J, Parkerson KA, Ticho B, Cross JH. Zorevunersen in Children and Adolescents with Dravet Syndrome. N Engl J Med. 2026 Mar 05; 394(10):969-982.
Score: 0.020
-
Scheffer IE, Perry MS, Sullivan J, Boronat S, Wheless J, Brunklaus A, Laux L, Patel AD, Roberts C, Dlugos D, Holder D, Knupp K, Lallas M, Phillips S, Segal E, Lal D, Wirrell E, Zuberi SM, Shaffer R, Wojnaroski M, Berl MM, Christensen S, James ES, Vila MC, Huang N, Gofshteyn JS, Rico S. Characterizing early behavioral and social-emotional problems in young children with SCN1A+ Dravet syndrome: Findings from the ENVISION prospective natural history study. Epilepsia. 2026 May; 67(5):2463-2479.
Score: 0.020
-
Sullivan J, Perry MS, Scheffer IE, Wheless J, Boronat S, Brunklaus A, Laux L, Patel AD, Roberts C, Dlugos D, Holder D, Knupp K, Lallas M, Phillips S, Segal E, Lal D, Wirrell E, Zuberi S, Gioia G, Shaffer R, Berl MM, Wojnaroski M, Christensen S, King A, James ES, Vila MC, Huang N, Gofshteyn JS, Rico S. Cognitive stagnation and executive function deficits in young children with SCN1A+ Dravet syndrome: Detailed characterization of onset, progression, and impact in the ENVISION natural history study. Epilepsia. 2026 Mar; 67(3):1284-1302.
Score: 0.020
-
Sullivan J, Wirrell EC, Knupp KG, Ciliberto M, Ziobro J, Chen DY, Flamini JR, Zafar M, LaVallee N, Stepanians M, Ventola P, Chavan TS, Wang F, Parkerson KA, Ticho B. Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-Up. Neurology. 2025 Dec 09; 105(11):e214388.
Score: 0.020
-
Barbour K, Hussain SA, Knupp KG, Berg AT, Chu CJ, Coryell J, Sánchez Fernández I, Gaillard WD, Harini C, Keator CG, Loddenkemper T, Mitchell WG, Mytinger JR, Nordli DR, Patel AD, Shellhaas RA, Singhal NS, Valencia I, Wirrell EC, Wusthoff CJ, Yozawitz EG, Grinspan ZM. Comparative effectiveness of second-line treatments for epileptic spasms. Epilepsia. 2025 Oct; 66(10):3799-3809.
Score: 0.019
-
Stillman C, Knupp K, Oliver J, Conley A, Kennedy K, Silveira L, Joshi C. A retrospective analysis of pediatric patients on a ketogenic diet: A comparison of inpatient versus outpatient diet initiations. Epilepsy Res. 2025 Aug; 214:107556.
Score: 0.019
-
Condon C, Parkerson KA, Dandurand A, Wang F, Howse C, Mayhew M, Whyman S, Ventola P, Anne Meskis M, Sullivan J, Knupp KG, Gater A, Mahon-Smith A. Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: Caregiver and clinician perspectives. Epilepsy Behav. 2025 Jun; 167:110381.
Score: 0.019
-
Figueroa AG, Fulton RE, Banerji R, Knupp KG, Patel MN. Mitochondrial respiration defects in lymphoblast cell lines from patients with Dravet syndrome. Epilepsia. 2025 Jul; 66(7):2507-2520.
Score: 0.019
-
Sullivan J, Wirrell E, Knupp KG, Chen D, Flamini R, Zafar M, Ventola P, Avendaño J, Wang F, Parkerson KA, Ticho B. Adaptive functioning and neurodevelopment in patients with Dravet syndrome: 12-month interim analysis of the BUTTERFLY observational study. Epilepsy Behav. 2024 02; 151:109604.
Score: 0.018
-
Perry MS, Scheffer IE, Sullivan J, Brunklaus A, Boronat S, Wheless JW, Laux L, Patel AD, Roberts CM, Dlugos D, Holder D, Knupp KG, Lallas M, Phillips S, Segal E, Smeyers P, Lal D, Wirrell E, Zuberi S, Brünger T, Wojnaroski M, Maru B, O'Donnell P, Morton M, James E, Vila MC, Huang N, Gofshteyn JS, Rico S. Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A+ Dravet syndrome: Insights from the ENVISION natural history study. Epilepsia. 2024 02; 65(2):322-337.
Score: 0.017
-
Sullivan J, Lagae L, Cross JH, Devinsky O, Guerrini R, Knupp KG, Laux L, Nikanorova M, Polster T, Talwar D, Ceulemans B, Nabbout R, Farfel GM, Galer BS, Gammaitoni AR, Lock M, Agarwal A, Scheffer IE. Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trial. Epilepsia. 2023 Oct; 64(10):2653-2666.
Score: 0.017
-
Bishop KI, Isquith PK, Gioia GA, Knupp KG, Scheffer IE, Nabbout R, Specchio N, Sullivan J, Auvin S, Helen Cross J, Guerrini R, Farfel G, Galer BS, Gammaitoni AR. Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment. Epilepsy Behav. 2023 01; 138:108994.
Score: 0.016
-
Sullivan J, Wirrell E, Knupp KG, Chen D, Zafar M, Flamini R, Stutely J, Brathwaite C, Ventola P, Avendaño J, Parkerson KA, Wyant N, Ticho B. Interim results of adaptive functioning and neurodevelopment in BUTTERFLY - An observational study of children and adolescents with Dravet syndrome. Epilepsy Behav. 2022 12; 137(Pt A):108955.
Score: 0.016
-
Berg AT, Gaebler-Spira D, Wilkening G, Zelko F, Knupp K, Dixon-Salazar T, Villas N, Meskis MA, Harwell V, Thompson T, Sims S, Nesbitt G. Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox-Gastaut syndrome, ESES: A functional framework. Epilepsy Behav. 2020 10; 111:107287.
Score: 0.014
-
Nabbout R, Mistry A, Zuberi S, Villeneuve N, Gil-Nagel A, Sanchez-Carpintero R, Stephani U, Laux L, Wirrell E, Knupp K, Chiron C, Farfel G, Galer BS, Morrison G, Lock M, Agarwal A, Auvin S. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial. JAMA Neurol. 2020 03 01; 77(3):300-308.
Score: 0.013
-
Lagae L, Sullivan J, Knupp K, Laux L, Polster T, Nikanorova M, Devinsky O, Cross JH, Guerrini R, Talwar D, Miller I, Farfel G, Galer BS, Gammaitoni A, Mistry A, Morrison G, Lock M, Agarwal A, Lai WW, Ceulemans B. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2019 12 21; 394(10216):2243-2254.
Score: 0.013
-
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, Knupp KG, Patel A, Sullivan JE, Kossoff EH, Chu CJ, Massey S, Valencia I, Keator C, Wirrell EC, Coryell J, Millichap JJ, Gaillard WD. Immediate outcomes in early life epilepsy: A contemporary account. Epilepsy Behav. 2019 08; 97:44-50.
Score: 0.013
-
Tolete P, Knupp K, Karlovich M, DeCarlo E, Bluvstein J, Conway E, Friedman D, Dugan P, Devinsky O. Lorcaserin therapy for severe epilepsy of childhood onset: A case series. Neurology. 2018 10 30; 91(18):837-839.
Score: 0.012
-
Coryell J, Gaillard WD, Shellhaas RA, Grinspan ZM, Wirrell EC, Knupp KG, Wusthoff CJ, Keator C, Sullivan JE, Loddenkemper T, Patel A, Chu CJ, Massey S, Novotny EJ, Saneto RP, Berg AT. Neuroimaging of Early Life Epilepsy. Pediatrics. 2018 09; 142(3).
Score: 0.012
-
Berg AT, Chakravorty S, Koh S, Grinspan ZM, Shellhaas RA, Saneto RP, Wirrell EC, Coryell J, Chu CJ, Mytinger JR, Gaillard WD, Valencia I, Knupp KG, Loddenkemper T, Sullivan JE, Poduri A, Millichap JJ, Keator C, Wusthoff C, Ryan N, Dobyns WB, Hegde M. Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms. PLoS One. 2018; 13(3):e0193599.
Score: 0.012
-
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR, Gaillard WD, Kossoff EH, Valencia I, Knupp KG, Wusthoff C, Keator C, Dobyns WB, Ryan N, Loddenkemper T, Chu CJ, Novotny EJ, Koh S. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 2017 09 01; 171(9):863-871.
Score: 0.011
-
Shellhaas RA, Berg AT, Grinspan ZM, Wusthoff CJ, Millichap JJ, Loddenkemper T, Coryell J, Saneto RP, Chu CJ, Joshi SM, Sullivan JE, Knupp KG, Kossoff EH, Keator C, Wirrell EC, Mytinger JR, Valencia I, Massey S, Gaillard WD. Initial Treatment for Nonsyndromic Early-Life Epilepsy: An Unexpected Consensus. Pediatr Neurol. 2017 Oct; 75:73-79.
Score: 0.011
-
Press CA, Knupp KG, Chapman KE. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. Epilepsy Behav. 2015 Apr; 45:49-52.
Score: 0.010
-
Barberio M, Reiter PD, Kaufman J, Knupp K, Dobyns EL. Continuous infusion pentobarbital for refractory status epilepticus in children. J Child Neurol. 2012 Jun; 27(6):721-6.
Score: 0.008
-
Reiter PD, Huff AD, Knupp KG, Valuck RJ. Intravenous levetiracetam in the management of acute seizures in children. Pediatr Neurol. 2010 Aug; 43(2):117-21.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|